Medications
Nateglinide - Starlix
STARLIX (nateglinide) is a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of use: Not for treating type 1 diabetes mellitus or diabetes ketoacidosis
• Common adverse reactions associated with STARLIX (3% or greater incidence) were upper respiratory tract infection, back pain, flu symptoms, dizziness, arthropathy, diarrhea.
• Drugs That May Increase the Potential for Hypoglycemia: STARLIX dose reductions and increased frequency of glucose monitoring may be required when co-administered
• Drugs That May Increase the Potential for Hyperglycemia: STARLIX dose increases and increased frequency of glucose monitoring may be required when co-administered
• Drugs That May Blunt Signs and Symptoms of Hypoglycemia: Increased frequency of glucose monitoring may be required when coadministered
• Hypoglycemia: STARLIX may cause hypoglycemia. Administer before meals to reduce the risk of hypoglycemia. Skip the scheduled dose of STARLIX if a meal is skipped to reduce the risk of hypoglycemia.
• Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with STARLIX.
